Improvement of Estradiol- 17β-D-Glucuronide-Induced Cholestasis by Sodium Tauroursodeoxycholate Therapy in Rats

References

• Heikel TA, Lathe GH. The effect of oral contraceptive steroids on bile secretion and bilirubin Tm in rats. Br J Pharmacol 1970; 38: 593–601
   PubMed Web of Science ®Google Scholar
• Metreau JM, Dhumeaux D, Berthelot P. Oral contraceptives and the liver. Digestion 1972; 7: 318–35
   PubMed Web of Science ®Google Scholar
• Bennion LJ, Ginsberg RL, Garnick MB, Bennett PH. Effects of oral contraceptives on the gallbladder bile of normal women. N Engl J Med 1976; 294: 189–92
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Svanborg A, Anberg A. Recurrent jaundice in pregnancy. II. A study of the estrogens and their conjugation in late pregnancy. Am J Med 1967; 42: 341–7
   PubMedGoogle Scholar
• Holzbach RT, Sanders JH. Recurrent intrahepatic cholestasis of pregnancy: observations on pathogenesis. JAMA 1965; 193: 542–4
   PubMed Web of Science ®Google Scholar
• Meyers M, Slikker W, Pascoe G, Vore M. Characterization of cholestasis induced by estradiol-17β-D-glucuronide in the rat. 5. Pharmacol Exp Ther 1980; 214: 87–93
   PubMed Web of Science ®Google Scholar
• Meyers M, Slikker W, Vore M. Steroid D-ring glucuronides: characterization of a new class of cholestatic agents in the rat. J Pharmacol Exp Ther 1981; 218: 63–73
   PubMed Web of Science ®Google Scholar
• Poupon R, Balkau B, Eschwege E, Poupon R. the UDCA-PBC study group. A multicenter controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991; 324: 1548–54
   PubMed Web of Science ®Google Scholar
• Leuschner U, Fischer H, Kurtz W, et al. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology 1989; 97: 1268–74
   PubMed Web of Science ®Google Scholar
• O'Brien CB, Senior JR, Arora-Mirchandani R, Batta AK, Salen G. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. Hepatology 1991; 14: 838–47
   PubMed Web of Science ®Google Scholar
• Cotting J, Lentze MJ, Reichen J. Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis. Gut 1990; 31: 918–21
   PubMedGoogle Scholar
• Nakagawa M, Colombo C, Setchell KDR. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. Hepatology 1990; 12: 322–34
   PubMedGoogle Scholar
• Ullrich D, Rating D, Schroter W, Hanefeld F, Bircher J. Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation. Lancet 1987; 2: 1324
   PubMedGoogle Scholar
• Lindor KD, Burnes J. Ursodeoxycholic acid for the treatment of home parenteral nutrition-associated cholestasis. A case report. Gastroenterology 1991; 101: 250–3
   PubMed Web of Science ®Google Scholar
• Balistreri WF, A-Kader HH, Heubi JE, Setchell KDR, Whitington P. Ursodeoxycholic acid (UDCA) decreases serum cholesterol levels, ameliorates symptoms, and improves biochemical parameters in pediatric patients with chronic intrahepatic cholestasis. Bile acids as therapeutic agents. Falk Symposium 58., G Paumgartner, A Stiehl, W Gerok. Kluwer Academic Publishers, London 1990; 323–33
   Google Scholar
• Jacquemin E, Dumont M, Mallet A, Erlinger S. Ursodeoxycholic acid improves ethinyl estradiol-induced cholestasis in the rats. Eur J Clin Invest 1993; 23: 794–802
   PubMedGoogle Scholar
• Kitani K, Ohta M, Kanai S. Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat. Am J Physiol 1985; 248: G407–17
   PubMedGoogle Scholar
• Scholmerich J, Baumgartner U, Miyai K, Gerok W. Tauroursodeoxycholate prevents taurolithocholate-induced cholestasis and toxicity in rat liver. J Hepatol 1990; 10: 280–3
   PubMedGoogle Scholar
• Kinbara S, Ishizaki K, Takeuchi Y, Miyazawa N, Araki T. Protection against a-naphthylisothiocyanate-induced acute cholestasis in mice by a novel taurine conjugate of ursodeoxy-cholate (UR-906). Jpn I Pharmacol 1993; 63: 125–7
   PubMedGoogle Scholar
• Sakakura H, Suzuki M, Kimura N, Takeda H, Nagata S, Maeda M. Simultaneous determination of bile acids in rat bile and serum by high-performance liquid chromatography. J Chroma-togr 1993; 621: 123–31
   PubMedGoogle Scholar
• Adinolfi LE, Utili R, Gaeta GB, Abernathy CO, Zimmerman HJ. Cholestasis induced by estradiol-17β-D-glucuronide: mechanisms and prevention by sodium taurocholate. Hepatology 1984; 4: 30–7
   PubMedGoogle Scholar
• Bouchard G, Yousef IM, Tuchweber B. Influence of oral treatment with ursodeoxycholic and tauroursodeoxycholic acids on estrogen-induced cholestasis in rats: effects on bile formation and liver plasma membranes. Liver 1993; 13: 193–202
   PubMedGoogle Scholar